Asia
Shukra Pharmaceuticals Swings to Consolidated Loss in Fiscal Q4
Shukra Pharmaceuticals (BOM:524632) booked a consolidated net loss of 17.2 million Indian rupees in the fiscal fourth quarter ended March 31 against a profit of 53.9 million rupees a year earlier.Shares of the company fell 5% in recent trade.Loss per share stood at 0.04 rupees compared with earnings per share of 0.12 rupees a year ago, according to a Thursday filing to the Indian stock exchanges.Net sales in fiscal Q4 slipped to 63.2 million rupees from 132.7 million rupees a year prior.
BOM:524632
